Dicerna Pharmaceuticals, Inc. - stock earnings
Stock symbol DRNA is outdated, potentially delisted? Maybe it is available on other exchange?
DRNA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021Q1 | -30.0 million USD | 47.6 million USD |
| 2020Q4 | -36.6 million USD | 41.0 million USD |
| 2020Q3 | -21.8 million USD | 48.9 million USD |
| 2020Q2 | -31.8 million USD | 40.4 million USD |
DRNA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | -112.7 million USD | 164.3 million USD |
| 2019 | -120.5 million USD | 23.9 million USD |
| 2018 | -88.9 million USD | 6.2 million USD |
| 2017 | -60.2 million USD | 1.0 million USD |
DRNA
Price: $38.22
52 week price:
Earnings Per Share: -1.65 USD
P/E Ratio: -14.22
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 796479
Ebitda: -15.0 millionMarket Capitalization: 2.9 billion